Gill SS - Search Results

1

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.

Whone AL, Boca M, Luz M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS. Whone AL, et al. Among authors: gill ss. J Parkinsons Dis. 2019;9(2):301-313. doi: 10.3233/JPD-191576. J Parkinsons Dis. 2019. PMID: 30829619 Free PMC article.

2

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.

Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P. Gill SS, et al. Nat Med. 2003 May;9(5):589-95. doi: 10.1038/nm850. Epub 2003 Mar 31. Nat Med. 2003. PMID: 12669033

3

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, Gill SS. Patel NK, et al. Among authors: gill ss. Ann Neurol. 2005 Feb;57(2):298-302. doi: 10.1002/ana.20374. Ann Neurol. 2005. PMID: 15668979 Clinical Trial.

4

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P, Brodsky MA, Burchiel K, Kelly P, Dalvi A, Scott B, Stacy M, Turner D, Wooten VG, Elias WJ, Laws ER, Dhawan V, Stoessl AJ, Matcham J, Coffey RJ, Traub M. Lang AE, et al. Ann Neurol. 2006 Mar;59(3):459-66. doi: 10.1002/ana.20737. Ann Neurol. 2006. PMID: 16429411 Clinical Trial.

5

GDNF delivery for Parkinson's disease.

Patel NK, Gill SS. Patel NK, et al. Among authors: gill ss. Acta Neurochir Suppl. 2007;97(Pt 2):135-54. doi: 10.1007/978-3-211-33081-4_16. Acta Neurochir Suppl. 2007. PMID: 17691299 Review.

6

A robust MRI-compatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal model.

White E, Woolley M, Bienemann A, Johnson DE, Wyatt M, Murray G, Taylor H, Gill SS. White E, et al. Among authors: gill ss. J Neurosci Methods. 2011 Jan 30;195(1):78-87. doi: 10.1016/j.jneumeth.2010.10.023. Epub 2010 Nov 11. J Neurosci Methods. 2011. PMID: 21074564 Free PMC article.

7

Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life.

Plaha P, Javed S, Agombar D, O' Farrell G, Khan S, Whone A, Gill S. Plaha P, et al. J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):899-904. doi: 10.1136/jnnp.2010.222992. Epub 2011 Feb 1. J Neurol Neurosurg Psychiatry. 2011. PMID: 21285454

8

Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.

Khan S, Mooney L, Plaha P, Javed S, White P, Whone AL, Gill SS. Khan S, et al. Among authors: gill ss. Br J Neurosurg. 2011 Apr;25(2):273-80. doi: 10.3109/02688697.2010.544790. Epub 2011 Feb 23. Br J Neurosurg. 2011. PMID: 21344974

9

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

Miners JS, Barua N, Kehoe PG, Gill S, Love S. Miners JS, et al. J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46. J Neuropathol Exp Neurol. 2011. PMID: 22002425 Review.

10

Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model.

Barua NU, Bienemann AS, Hesketh S, Wyatt MJ, Castrique E, Love S, Gill SS. Barua NU, et al. Among authors: gill ss. Fluids Barriers CNS. 2012 Jan 20;9(1):2. doi: 10.1186/2045-8118-9-2. Fluids Barriers CNS. 2012. PMID: 22264361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

631 results

Search Page